Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $2.30 $3.38 Friday, 10th May 2024 CLLS stock ended at $3.06. This is 5.56% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 9.00% from a day low at $3.00 to a day high of $3.27.
90 days $2.30 $3.38
52 weeks $0.96 $3.77

Historical Cellectis S.A. prices

Date Open High Low Close Volume
Sep 16, 2016 $25.16 $25.25 $24.76 $25.05 63 900
Sep 15, 2016 $25.32 $25.69 $25.10 $25.36 44 500
Sep 14, 2016 $24.94 $25.68 $24.83 $25.48 69 900
Sep 13, 2016 $25.29 $25.39 $24.14 $24.76 118 000
Sep 12, 2016 $25.05 $25.89 $25.00 $25.89 87 000
Sep 09, 2016 $25.91 $26.07 $25.33 $25.33 76 300
Sep 08, 2016 $26.04 $26.60 $25.85 $26.39 114 500
Sep 07, 2016 $26.41 $26.46 $25.81 $26.11 33 100
Sep 06, 2016 $26.31 $26.75 $26.27 $26.30 50 100
Sep 02, 2016 $26.17 $26.60 $25.76 $26.40 35 600
Sep 01, 2016 $26.47 $26.48 $26.03 $26.40 74 600
Aug 31, 2016 $25.91 $26.65 $25.71 $26.52 133 800
Aug 30, 2016 $26.49 $26.78 $26.26 $26.43 93 800
Aug 29, 2016 $26.41 $26.94 $26.18 $26.46 31 000
Aug 26, 2016 $26.58 $27.27 $26.26 $26.56 36 300
Aug 25, 2016 $27.11 $27.18 $26.12 $26.46 55 700
Aug 24, 2016 $27.22 $28.03 $26.85 $26.97 88 700
Aug 23, 2016 $27.33 $27.48 $26.53 $27.08 270 800
Aug 22, 2016 $26.32 $27.00 $26.11 $26.65 139 100
Aug 19, 2016 $26.76 $26.76 $25.81 $25.90 89 600
Aug 18, 2016 $27.19 $27.32 $26.42 $26.71 114 900
Aug 17, 2016 $27.64 $27.65 $27.04 $27.14 67 200
Aug 16, 2016 $28.34 $28.46 $27.87 $27.87 29 500
Aug 15, 2016 $28.01 $28.45 $27.95 $28.23 88 600
Aug 12, 2016 $27.17 $27.75 $27.04 $27.59 98 500
Click to get the best stock tips daily for free!

About Cellectis S.A.

Cellectis S.A. Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatment of CD19-expressing hematologic malignancies, such as acute lymphoblastic leukemia; ALLO-501 and ALL... CLLS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT